Select Page

In this report, the Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Glutamate Receptor Ionotropic NMDA 2B for these regions, from 2013 to 2025 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B market competition by top manufacturers/players, with Glutamate Receptor Ionotropic NMDA 2B sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including BioCrea GmbH Bristol-Myers Squibb Company Cerecor Inc. Johnson & Johnson Luc Therapeutics, Inc. NeurOp, Inc Novartis AG UCB S.A. On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into JNJ-0808 Neu-2000 NP-10679 NP-11948 Radiprodil Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Acute Ischemic Stroke Autism Brasin Ischemia Burns Others If you have any special requirements, please let us know and we will offer you the report as you want.

Get sample copy of the report:
www.marketdensity.com/contact?ref=Sample&reportid=22534

Table of Contents:
Table of Contents

Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Report 2018
1 Glutamate Receptor Ionotropic NMDA 2B Overview
1.1 Product Overview and Scope of Glutamate Receptor Ionotropic NMDA 2B
1.2 Classification of Glutamate Receptor Ionotropic NMDA 2B by Product Category
1.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (Sales) Comparison by Types (2013-2025)
1.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 JNJ-0808
1.2.4 Neu-2000
1.2.5 NP-10679
1.2.6 NP-11948
1.2.7 Radiprodil
1.2.8 Others
1.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market by Application/End Users
1.3.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales (Volume) and Market Share Comparison by Applications (2013-2025)
1.3.2 Acute Ischemic Stroke
1.3.3 Autism
1.3.4 Brasin Ischemia
1.3.5 Burns
1.3.6 Others
1.4 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market by Region
1.4.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (Value) Comparison by Region (2013-2025)
1.4.2 China Status and Prospect (2013-2025)
1.4.3 Japan Status and Prospect (2013-2025)
1.4.4 South Korea Status and Prospect (2013-2025)
1.4.5 Taiwan Status and Prospect (2013-2025)
1.4.6 India Status and Prospect (2013-2025)
1.4.7 Southeast Asia Status and Prospect (2013-2025)
1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Glutamate Receptor Ionotropic NMDA 2B (2013-2025)
1.5.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales and Growth Rate (2013-2025)
1.5.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2025)

2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B (Volume and Value) by Type
2.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales and Market Share by Type (2013-2018)
2.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B (Volume) by Application
2.4 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B (Volume and Value) by Region
2.4.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales and Market Share by Region (2013-2018)
2.4.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Region (2013-2018)

3 China Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
3.1 China Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
3.1.1 China Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
3.1.2 China Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
3.1.3 China Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
3.2 China Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
3.3 China Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

4 Japan Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
4.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
4.1.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
4.1.2 Japan Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
4.1.3 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
4.2 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
4.3 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

5 South Korea Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
5.1 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
5.1.1 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
5.1.2 South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
5.1.3 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
5.2 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
5.3 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

6 Taiwan Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
6.1 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
6.1.1 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
6.1.2 Taiwan Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
6.1.3 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
6.2 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
6.3 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

7 India Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
7.1 India Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
7.1.1 India Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
7.1.2 India Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
7.1.3 India Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
7.2 India Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
7.3 India Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

8 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
8.1 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
8.1.1 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
8.1.2 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
8.1.3 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
8.2 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
8.3 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

9 Australia Glutamate Receptor Ionotropic NMDA 2B (Volume, Value and Sales Price)
9.1 Australia Glutamate Receptor Ionotropic NMDA 2B Sales and Value (2013-2018)
9.1.1 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate (2013-2018)
9.1.2 Australia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2013-2018)
9.1.3 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Price Trend (2013-2018)
9.2 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Type
9.3 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Market Share by Application

10 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Players/Suppliers Profiles and Sales Data
10.1 BioCrea GmbH
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.1.4 Main Business/Business Overview
10.2 Bristol-Myers Squibb Company
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.2.4 Main Business/Business Overview
10.3 Cerecor Inc.
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.4.4 Main Business/Business Overview
10.5 Luc Therapeutics, Inc.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.5.4 Main Business/Business Overview
10.6 NeurOp, Inc
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.6.4 Main Business/Business Overview
10.7 Novartis AG
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.7.4 Main Business/Business Overview
10.8 UCB S.A.
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Glutamate Receptor Ionotropic NMDA 2B Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2013-2018)
10.8.4 Main Business/Business Overview

11 Glutamate Receptor Ionotropic NMDA 2B Manufacturing Cost Analysis
11.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Glutamate Receptor Ionotropic NMDA 2B Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Glutamate Receptor Ionotropic NMDA 2B Major Manufacturers in 2017
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Forecast (2018-2025)
15.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Volume, Revenue and Price Forecast (2018-2025)
15.1.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate Forecast (2018-2025)
15.1.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate Forecast (2018-2025)
15.1.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
15.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Volume and Growth Rate Forecast by Region (2018-2025)
15.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate Forecast by Region (2018-2025)
15.2.3 China Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.4 Japan Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.5 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.6 Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.7 India Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.8 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.2.9 Australia Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Price Forecast by Type (2018-2025)
15.3.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type (2018-2025)
15.3.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Type (2018-2025)
15.3.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application (2018-2025)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer

Buy this report online:
www.marketdensity.com/asia-pacific-glutamate-receptor-ionotropic-nmda-2b-market-report